Skip to content

Study · Measured the body's own peptide · 2017

3 results

Endogenous Thymosin β4 Expression in Sacrococcygeal Pilonidal Sinus Disease: A Retrospective, Immunohistochemical Analysis of Excisional Skin Biopsy Samples.

Sahin S

Ostomy/wound management1 Apr 2017Cited by 1 (Europe PMC)

PMID28448267 (opens in a new tab)PepBankPUB-28448267

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Natural levels measured3

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In patients with sacrococcygeal pilonidal sinus disease, endogenous Tβ4 expression in the epidermis was higher in inflamed sinus tract tissue than in noninflamed tissue.

    In plain wordsIn people with pilonidal sinus disease, the body's own Tβ4 was higher in inflamed skin than in nearby normal skin.

    Outcome
    IncreaseTβ4 expression score in epidermis
    Study

    n = 31

    Comparator
    Noninflamed normal tissue adjacent to the sinus tract
    Outcome group
    Inflammation markers · Skin and wound

    Measurements

    Tβ4 expression score
    2.4 score
    inflamed sinus tract epidermis
    Tβ4 expression score
    0.8 score
    noninflamed epidermis

    Source sentences

    Summary
    Inflamed sinus tract tissue had significantly higher Tβ4 expression scores than noninflamed tissue samples in the epidermis (2.4 ± 0.8 [1.0-3.0] versus 0.8 ± 0.5 [0.0-2.0], P = .000), dermal/subcutaneous collagen (2.6 ± 0.5 [2.0-3.0] versus 1.6 ± 0.5 [1.0-2.0], P = .000), and vascular structure (2.6…
    2 context sentences
    Summary · context
    Two (2) samples were cut from each specimen and prepared for histopathological assessment: 1 from the inflamed sinus tracts containing hair and granulation tissue (chronic wound group) and 1 from the normal tissue at least 1 cm away from the sinus tract (control group).
    Summary · context
    A total of 31 excisional skin biopsy specimens were available from 31 patients with SPSD (mean age 26.0 ± 7.6 years, 25 [80.6%] men, 6 [19.4%] women) who underwent primary surgical closure.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

  2. 02HumanEndogenous levelObservational studyOther

    In patients with sacrococcygeal pilonidal sinus disease, endogenous Tβ4 expression in dermal/subcutaneous collagen was higher in inflamed sinus tract tissue than in noninflamed tissue.

    In plain wordsIn people with pilonidal sinus disease, the body's own Tβ4 in deeper skin tissue was higher in inflamed areas than in nearby normal areas.

    Outcome
    IncreaseTβ4 expression score in dermal/subcutaneous collagen
    Study

    n = 31

    Comparator
    Noninflamed normal tissue adjacent to the sinus tract
    Outcome group
    Inflammation markers · Skin and wound

    Measurements

    Tβ4 expression score
    2.6 score
    inflamed sinus tract collagen
    Tβ4 expression score
    1.6 score
    noninflamed collagen

    Source sentences

    Summary
    Inflamed sinus tract tissue had significantly higher Tβ4 expression scores than noninflamed tissue samples in the epidermis (2.4 ± 0.8 [1.0-3.0] versus 0.8 ± 0.5 [0.0-2.0], P = .000), dermal/subcutaneous collagen (2.6 ± 0.5 [2.0-3.0] versus 1.6 ± 0.5 [1.0-2.0], P = .000), and vascular structure (2.6…
    2 context sentences
    Summary · context
    Two (2) samples were cut from each specimen and prepared for histopathological assessment: 1 from the inflamed sinus tracts containing hair and granulation tissue (chronic wound group) and 1 from the normal tissue at least 1 cm away from the sinus tract (control group).
    Summary · context
    A total of 31 excisional skin biopsy specimens were available from 31 patients with SPSD (mean age 26.0 ± 7.6 years, 25 [80.6%] men, 6 [19.4%] women) who underwent primary surgical closure.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

  3. 03HumanEndogenous levelObservational studyOther

    In patients with sacrococcygeal pilonidal sinus disease, endogenous Tβ4 expression in vascular structures was higher in inflamed sinus tract tissue than in noninflamed tissue.

    In plain wordsIn people with pilonidal sinus disease, the body's own Tβ4 in blood vessel structures was higher in inflamed areas than in nearby normal areas.

    Outcome
    IncreaseTβ4 expression score in vascular structure
    Study

    n = 31

    Comparator
    Noninflamed normal tissue adjacent to the sinus tract
    Outcome group
    Inflammation markers · Skin and wound

    Measurements

    Tβ4 expression score
    2.6 score
    inflamed sinus tract vascular structure
    Tβ4 expression score
    1.1 score
    noninflamed vascular structure

    Source sentences

    Summary
    Inflamed sinus tract tissue had significantly higher Tβ4 expression scores than noninflamed tissue samples in the epidermis (2.4 ± 0.8 [1.0-3.0] versus 0.8 ± 0.5 [0.0-2.0], P = .000), dermal/subcutaneous collagen (2.6 ± 0.5 [2.0-3.0] versus 1.6 ± 0.5 [1.0-2.0], P = .000), and vascular structure (2.6…
    2 context sentences
    Summary · context
    Two (2) samples were cut from each specimen and prepared for histopathological assessment: 1 from the inflamed sinus tracts containing hair and granulation tissue (chronic wound group) and 1 from the normal tissue at least 1 cm away from the sinus tract (control group).
    Summary · context
    A total of 31 excisional skin biopsy specimens were available from 31 patients with SPSD (mean age 26.0 ± 7.6 years, 25 [80.6%] men, 6 [19.4%] women) who underwent primary surgical closure.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.